The estimated Net Worth of Thomas A Szlosek is at least $14.4 Million dollars as of 7 August 2024. Mr. Szlosek owns over 3,195 units of Avantor stock worth over $124,217 and over the last 11 years he sold AVTR stock worth over $10,291,955. In addition, he makes $3,977,060 as Chief Financial Officer and Executive Vice President at Avantor.
Sign up
Mr. Szlosek AVTR stock SEC Form 4 insiders trading
Thomas has made over 12 trades of the Avantor stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 3,195 units of AVTR stock worth $85,977 on 7 August 2024.
The largest trade he's ever made was exercising 64,778 units of Avantor stock on 29 February 2016 worth over $6,756,993. On average, Thomas trades about 3,563 units every 51 days since 2014. As of 7 August 2024 he still owns at least 4,616 units of Avantor stock.
You can see the complete history of Mr. Szlosek stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Szlosek biography
Thomas Szlosek is Executive Vice President and Chief Financial Officer of the company. Mr. Thomas Szlosek is our Executive Vice President and Chief Financial Officer, a position he has held since December 2018. Mr. Szlosek previously served as the Senior Vice President and Chief Financial Officer of Honeywell International, Inc., a diversified technology and manufacturing company, from April 2014 to August 2018. Mr. Szlosek is also a Certified Public Accountant.
What is the salary of Thomas Szlosek?
As the Chief Financial Officer and Executive Vice President of Avantor, the total compensation of Thomas Szlosek at Avantor is $3,977,060. There are 1 executives at Avantor getting paid more, with Michael Stubblefield having the highest compensation of $16,995,300.
How old is Thomas Szlosek?
Thomas Szlosek is 56, he's been the Chief Financial Officer and Executive Vice President of Avantor since 2018. There are 5 older and 26 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.
What's Thomas Szlosek's mailing address?
Thomas's mailing address filed with the SEC is 200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE, FL, 33301.
Insiders trading at Avantor
Over the last 6 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri, and Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.
What does Avantor do?
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com
What does Avantor's logo look like?
Complete history of Mr. Szlosek stock trades at Autonation, Honeywell International Inc, and Avantor
Avantor executives and stock owners
Avantor executives and other stock owners filed with the SEC include:
-
Michael Stubblefield,
President, Chief Executive Officer, Director -
Thomas Szlosek,
Chief Financial Officer, Executive Vice President -
Michael Stubblefield,
Pres, CEO & Director -
Gerard Brophy,
Executive Vice President - Biopharma Production -
Devashish Ohri,
Executive Vice President - AMEA -
Frederic Vanderhaegen,
Executive Vice President - Americas and Europe -
Thomas A. Szlosek,
Exec. VP & CFO -
Frederic Vanderhaegen,
Exec. VP of Americas & Europe -
Dr. Gerald Brophy Ph.D.,
Exec. VP of Biopharma Production -
Michael Wondrasch,
Exec. VP & Chief Information Officer -
Rajiv Gupta,
Chairman of the Board -
Jonathan Peacock,
Independent Director -
Christi Shaw,
Independent Director -
Rakesh Sachdev,
Independent Director -
Juan Andres,
Independent Director -
Gregory Summe,
Independent Director -
Michael Severino,
Independent Director -
Jo Natauri,
Director -
Andre Moura,
Director -
Matthew Holt,
Director -
Steven Eck,
Senior Vice President, Chief Accounting Officer -
Mark Murray,
Executive Vice President of the Biomaterials and Advanced Technologies Platform -
Sven Henrichwark,
Executive Vice President of APAC -
Tanya Foxe,
Executive Vice President - Global Operations and Supply Chain -
Christophe Couturier,
Executive Vice President - Services, Strategy and Business Transformation -
James Bramwell,
Executive Vice President - Strategic Partners -
Justin Miller,
Executive Vice President, General Counsel, Secretary -
Michael Wondrasch,
Executive Vice President, Chief Information Officer -
Eric McAllister,
Chief Human Resource Officer, Executive Vice President -
Allison K. Hosak,
Sr. VP of Global Communications & Brand -
Justin M. Miller Esq.,
Exec. VP, Gen. Counsel & Sec. -
Tommy J. Thomas CPA,
VP of Investor Relations -
Steven W. Eck,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Sheri Lewis,
Exec. VP, Global Operations & Supply Chain -
Lan Kang,
Director -
John Carethers,
Director -
Sachs & Co. Llc Stone Bridg...,
-
Sachs & Co. Llc Stone Bridg...,
-
Sheri Lewis,
EVP, Global Ops & Supply Chain -
Mountain Investments Iii, L...,
-
Mala Murthy,
Director -
Brittany Hankamer,
EVP, Chief HR Officer -
Randy Lee Stone,
EVP, Laboratory Solutions -
Corey Walker,
President Laboratory Solutions -
Ashish Kulkarni,
See Remarks -
Sachs & Co. Llcgoldman Sach...,
-
Meghan Henson,
EVP, Chief HR Officer -
Thomas Connolly,
Director -
Joseph R Massaro,
Director -
Kitty Sahin,
EVP, Strategy&Corp Development -
Claudius Sokenu,
EVP, Chief Legal & Compliance -
R. Brent Jones,
EVP, Chief Financial Officer -
Benoit Gourdier,
EVP, Biopharma Production